KOHEI MIZUTA

Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, Ryosuke Mori et al. · Anticancer Research · 2024 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA et al. · In Vivo · 2024 · 21 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +13

Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer

MOTOKAZU SATO, Qinghong Han, Yutaro Kubota et al. · Anticancer Research · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug

Yutaro Kubota, Qinghong Han, Sei Morinaga et al. · Cancer Diagnosis & Prognosis · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacology +12

Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells

DANIEL ARDJMAND, Yutaro Kubota, MOTOKAZU SATO et al. · Anticancer Research · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +15